Format

Send to

Choose Destination
Open Forum Infect Dis. 2014 Jul 8;1(2):ofu046. doi: 10.1093/ofid/ofu046. eCollection 2014 Sep.

Ceftaroline in Combination With Trimethoprim-Sulfamethoxazole for Salvage Therapy of Methicillin-Resistant Staphylococcus aureus Bacteremia and Endocarditis.

Author information

1
Division of Infectious Diseases , Johns Hopkins University School of Medicine , Baltimore, Maryland.
2
Division of Infectious Diseases , Johns Hopkins University School of Medicine , Baltimore, Maryland ; Critical Care Medicine Department, National Institutes of Health, Bethesda, Maryland.
3
Department of Pharmacy , Intermountain Medical Center , Murray, Utah.
4
Department of Pharmacy , Johns Hopkins Hospital , Baltimore, Maryland.

Erratum in

Abstract

No clinical trials have investigated the use of ceftaroline fosamil for salvage therapy of methicillin-resistant Staphylococcus aureus bacteremia and endocarditis. We report data on 29 patients who received ceftaroline ± another antimicrobial for this indication. Ninety percent of patients had microbiologic cure and 31% had treatment success with a median follow-up of 6 months.

KEYWORDS:

MRSA; bacteremia; ceftaroline fosamil; salvage

Supplemental Content

Full text links

Icon for Silverchair Information Systems Icon for PubMed Central
Loading ...
Support Center